Building Your Care Team and Staying Proactive
At a Glance
Managing Bardet-Biedl syndrome (BBS) requires a multidisciplinary team of specialists, including nephrologists, ophthalmologists, and endocrinologists. Following an annual surveillance schedule for kidney, eye, and metabolic health is crucial for preventing long-term complications.
Because Bardet-Biedl Syndrome (BBS) affects multiple systems, your health depends on a team of experts working together. Building this team and maintaining a strict schedule of check-ups can help prevent complications and improve your long-term quality of life [1][2].
Your Multidisciplinary Care Team
A “multidisciplinary” team is one where specialists from different fields talk to each other to manage your health as a whole. Key members of your team should include [2][3]:
- Nephrologist (Kidney Specialist): Monitors kidney structure and function, which is critical for long-term health [4].
- Ophthalmologist (Eye Specialist): Tracks retinal changes and provides support for vision loss [5].
- Endocrinologist: Manages weight, metabolic health, hormone levels, and fertility questions [6].
- Geneticist / Genetic Counselor: Helps confirm the diagnosis and explains risks for other family members [1].
- Dietitian: Provides practical strategies for managing weight and hyperphagia [2].
- Psychologist / Mental Health Professional: Supports learning, behavior, and emotional well-being [7][8].
The Annual Surveillance Schedule
Recent 2024 consensus guidelines from the European Reference Network (ERN) emphasize that follow-up must be lifelong [1]. Use this checklist to ensure no system is overlooked:
| System | What to Check | Frequency |
|---|---|---|
| Kidneys | Blood pressure, eGFR (blood test), and protein levels (urine test) [1][9]. | Every 6-12 Months |
| Eyes | Visual acuity, visual fields, and imaging (OCT/ERG) to monitor retinal health [5][10]. | Annually |
| Metabolic | Weight, HbA1c (blood sugar), and lipid (cholesterol) panels [1][11]. | Annually |
| Liver | Liver function tests to monitor for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) [12]. | Annually |
| Imaging | Renal ultrasound to look for structural changes like cysts or shrinkage [1][13]. | As directed (often every 1-2 years) |
Managing Adult Care and Transitions
If you are transitioning from pediatric to adult care, or navigating the medical system as a newly diagnosed adult, autonomy is vital. Unlike pediatrics, adult care requires the patient to be highly independent.
- The Medical Binder: Keep a comprehensive binder (physical or digital) containing:
- Focus on Autonomy: Be direct with your doctors and advocate for your needs. If you are a parent of a teen, encourage them to ask the doctors questions directly to build confidence [2].
- Adult Comorbidities: Be aware that as you age, you may face new challenges such as Type 2 diabetes or metabolic syndrome, making continued multidisciplinary monitoring even more important [16][17].
Consistent monitoring is the best tool you have to protect your health and stay proactive [18][19].
Common questions in this guide
What specialists should be on a Bardet-Biedl syndrome care team?
How often should I have my kidneys checked if I have BBS?
What tests are included in the annual surveillance schedule for BBS?
What is the best way to keep track of my BBS medical records?
How does BBS care change when transitioning to adulthood?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Who is the lead 'quarterback' physician on my team who will coordinate between the different specialists?
- 2.Can you provide a written surveillance checklist based on the 2024 ERN consensus guidelines for me to keep?
- 3.What are the specific signs that would require me to move an annual check-up (like kidney or vision) to a sooner date?
- 4.Do you have experience working with specialists who understand the complexities of adult care for BBS?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (19)
- 1
Bardet-Biedl syndrome improved diagnosis criteria and management: Inter European Reference Networks consensus statement and recommendations.
Dollfus H, Lilien MR, Maffei P, et al.
European journal of human genetics : EJHG 2024; (32(11)):1347-1360 doi:10.1038/s41431-024-01634-7.
PMID: 39085583 - 2
Monitoring and Management of Bardet-Biedl Syndrome: What the Multi-Disciplinary Team Can Do.
Caba L, Florea L, Braha EE, et al.
Journal of multidisciplinary healthcare 2022; (15()):2153-2167 doi:10.2147/JMDH.S274739.
PMID: 36193191 - 3
[Ophthalmological care of patients with Bardet-Biedl syndrome].
Mahler EA, Kochs CL, Saßmannshausen M, et al.
Die Ophthalmologie 2025; doi:10.1007/s00347-025-02339-y.
PMID: 41238926 - 4
Renal Pathology of Ciliopathies.
Sekar T, Sebire NJ
Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society 2024; (27(5)):411-425 doi:10.1177/10935266241242173.
PMID: 38616607 - 5
Ophthalmologic Manifestations in Bardet-Biedl Syndrome: Emerging Therapeutic Approaches.
Rosado A, Rodriguez E, Izquierdo N
Medicina (Kaunas, Lithuania) 2025; (61(7)) doi:10.3390/medicina61071135.
PMID: 40731764 - 6
Bardet-Biedl syndrome: A focus on genetics, mechanisms and metabolic dysfunction.
Tomlinson JW
Diabetes, obesity & metabolism 2024; (26 Suppl 2()):13-24 doi:10.1111/dom.15480.
PMID: 38302651 - 7
Psychosis as a rare neuropsychiatric manifestation of Bardet-Biedl syndrome: A case report.
Moremi S, Hubona M, Maphorisa T, Olashore AA
The Journal of international medical research 2025; (53(9)):3000605251379249 doi:10.1177/03000605251379249.
PMID: 40992902 - 8
Laurence-Moon-Bardet-Biedl Syndrome: A Rare Case With a Literature Review.
Kumar A, Husain A, Saleem A, et al.
Cureus 2020; (12(11)):e11355 doi:10.7759/cureus.11355.
PMID: 33304690 - 9
Ultrasound evaluation of kidney and liver involvement in Bardet-Biedl syndrome.
Cetiner M, Finkelberg I, Schiepek F, et al.
Orphanet journal of rare diseases 2024; (19(1)):425 doi:10.1186/s13023-024-03400-w.
PMID: 39533427 - 10
Ciliopathy: Bardet-Biedl Syndrome.
Tsang SH, Aycinena ARP, Sharma T
Advances in experimental medicine and biology 2018; (1085()):171-174 doi:10.1007/978-3-319-95046-4_33.
PMID: 30578506 - 11
Cutaneous findings in Bardet-Biedl syndrome.
Haws RM, McIntee TJ, Green CB
International journal of dermatology 2019; (58(10)):1160-1164 doi:10.1111/ijd.14412.
PMID: 30790276 - 12
Impact of the Melanocortin-4 Receptor Agonist Setmelanotide on MASLD and Kidney Function in Bardet-Biedl Syndrome.
Hühne T, Polichronidou IM, Finkelberg I, et al.
The Journal of clinical endocrinology and metabolism 2026; (111(3)):721-733 doi:10.1210/clinem/dgaf483.
PMID: 40903014 - 13
Bardet-Biedl syndrome in a 19-year-old male: the first case report from Palestine.
Karmi HB, Abu Jwaid Y, Shehadeh MH, et al.
Frontiers in pediatrics 2024; (12()):1420684 doi:10.3389/fped.2024.1420684.
PMID: 38919843 - 14
CKD in Bardet-Biedl Syndrome: Evidence Supporting Multifactorial Etiology.
Zacchia M, Secondulfo F, Melluso A, et al.
Kidney international reports 2025; (10(2)):375-385 doi:10.1016/j.ekir.2024.10.030.
PMID: 39990901 - 15
Patient and caregiver experiences with a patient-support program for setmelanotide treatment of patients with Bardet-Biedl syndrome.
Finkelberg I, Polichronidou IM, Hühne T, et al.
Orphanet journal of rare diseases 2025; (20(1)):290 doi:10.1186/s13023-025-03835-9.
PMID: 40484968 - 16
Bardet-Biedl Syndrome Presenting in Adulthood.
Ankleshwaria C, Prajapati B, Parmar S, et al.
Indian journal of nephrology 2022; (32(6)):633-636 doi:10.4103/ijn.ijn_320_21.
PMID: 36704599 - 17
The Endocrine and Metabolic Characteristics of a Large Bardet-Biedl Syndrome Clinic Population.
Mujahid S, Hunt KF, Cheah YS, et al.
The Journal of clinical endocrinology and metabolism 2018; (103(5)):1834-1841 doi:10.1210/jc.2017-01459.
PMID: 29409041 - 18
Bangladeshi Case Series of Bardet-Biedl Syndrome.
Osman F, Iqbal MI, Islam MN, Kabir SJ
Case reports in ophthalmological medicine 2023; (2023()):4017010 doi:10.1155/2023/4017010.
PMID: 37096247 - 19
Rarity of Laurence Moon Bardet Biedl Syndrome and its Poor Management in the Pakistani Population.
Khan OA, Majeed R, Saad M, et al.
Cureus 2019; (11(2)):e4114 doi:10.7759/cureus.4114.
PMID: 31058008
This guide on managing Bardet-Biedl syndrome is for informational purposes only and does not replace professional medical advice. Always consult your specialized care team to develop a personalized lifelong surveillance plan.
Get notified when new evidence is published on Bardet-Biedl syndrome.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.